Save time and jump to the most important pieces.
SunLink Health Systems, Inc. (NYSE:SSY) today announced that its Board of Directors (a) declared a dividend of one one-thousandth (1/1,000th) of a share (each a "Series C Fractional Interest") of the Company's newly-designated Series C Redeemable Preferred Shares, no par value per share (the "Series C Preferred Shares"), for each outstanding common share of the Company (the "Common Shares"), payable on August 16, 2023 to shareholders of record as of 5:00 p.m. Eastern Time on August 15, 2023 and (b) its intent to call a special meeting of shareholders to consider and approve a proposal to reincorporate the Company as a Georgia corporation (the "Reincorporation Proposal"). The outstanding S
Gainers Concord Medical Services (NYSE:CCM) shares moved upwards by 131.0% to $4.85 during Tuesday's after-market session. The company's market cap stands at $210.6 million. Calidi Biotherapeutics (AMEX:CLDI) stock increased by 4.26% to $0.21. The market value of their outstanding shares is at $10.8 million. Anitra (AMEX:AZTR) shares moved upwards by 2.69% to $0.18. The market value of their outstanding shares is at $5.0 million. MAIA Biotechnology (AMEX:MAIA) stock rose 0.79% to $3.79. The company's market cap stands at $82.7 million. Emergent BioSolutions (NYSE:EBS) shares moved upwards by 0.53% to $5.59. The market value of their outstanding shares is at $292.9 million. Asensus Surg
SunLink Health Systems Inc (NASDAQ:SSY) shares are trading higher by 13.4% to $0.68 during Tuesday's session after the company late Monday announced that its subsidiary, Southern Health Corporation of Houston, has sold the Trace Extended Care & Rehab senior care facility and related real estate in Houston, Mississippi for around $7.1 million. The net proceeds of about $6.5 million will be used for working capital and general corporate purposes. The sale is expected to result in a pre-tax gain of approximately $5.7 million in the fourth fiscal quarter ending June 30. This sale aligns with SunLink’s strategy to position itself for a potential extraordinary transaction, such as a merger
10-Q - SUNLINK HEALTH SYSTEMS INC (0000096793) (Filer)
10-K/A - SUNLINK HEALTH SYSTEMS INC (0000096793) (Filer)
10-K - SUNLINK HEALTH SYSTEMS INC (0000096793) (Filer)
4 - SUNLINK HEALTH SYSTEMS INC (0000096793) (Issuer)
4 - SUNLINK HEALTH SYSTEMS INC (0000096793) (Issuer)
4 - SUNLINK HEALTH SYSTEMS INC (0000096793) (Issuer)
4 - SUNLINK HEALTH SYSTEMS INC (0000096793) (Issuer)
SC 13D/A - SUNLINK HEALTH SYSTEMS INC (0000096793) (Subject)
SC 13D/A - SUNLINK HEALTH SYSTEMS INC (0000096793) (Subject)
SC 13D/A - SUNLINK HEALTH SYSTEMS INC (0000096793) (Subject)
SunLink Health Systems, Inc. (NYSE:SSY) today announced a loss from continuing operations of $442,000 (or a loss of $0.06 per fully diluted share) for its first fiscal quarter ended September 30, 2024 compared to a loss from continuing operations of $428,000 (or a loss of $0.06 per fully diluted share) for the first fiscal quarter ended September 30, 2023. During the quarter ended September 30, 2024, the Company sold non-core assets for cash totaling $1,465,000, which resulted in an aggregate pre-tax gain of $694,000 in the quarter ended September 30, 2024. Net loss for the quarter ended September 30, 2024 was $549,000 (or a loss of $0.08 per fully diluted share) compared to a net loss of
SunLink Health Systems, Inc. (NYSE:SSY) today announced that its subsidiary, Southern Health Corporation of Houston, Inc., and an affiliate, have completed the sale of the hospital building and related real estate of its formerly operated Trace Regional Hospital in Houston, Mississippi for approximately $2,000,000. The company said the net proceeds of approximately $1,932,000 will be retained for working capital and general corporate purposes. The company expects to recognize a pre-tax loss on the sale of approximately $91,000 in its second fiscal quarter ending December 31, 2024. SunLink noted that the sale is intended to further its strategy of positioning itself for the possibility of a
SunLink Health Systems, Inc. (NYSE:SSY) today announced a loss from continuing operations of $652,000 (or a loss of $0.09 per fully diluted share) for its fourth fiscal quarter ended June 30, 2024 compared to a loss from continuing operations of $1,021,000 (or a loss of $0.15 per fully diluted share) for the fourth fiscal quarter ended June 30, 2023. Earnings from discontinued operations were $4,940,000 (or earnings of $0.70 per fully diluted share) for the fourth fiscal quarter ended June 30, 2024 compared to a loss from discontinued operations of $405,000 (or a loss of $0.06 per fully diluted share) for the fourth fiscal quarter ended June 30, 2023. During the quarter ended June 30, 2024